203 related articles for article (PubMed ID: 34584037)
21. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
22. Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean Breast Cancer Society.
Moon HG; Han W; Noh DY
J Clin Oncol; 2010 Apr; 28(10):1692-9. PubMed ID: 20194848
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis.
Chiba A; Bawaneh A; Velazquez C; Clear KYJ; Wilson AS; Howard-McNatt M; Levine EA; Levi-Polyachenko N; Yates-Alston SA; Diggle SP; Soto-Pantoja DR; Cook KL
Mol Cancer Res; 2020 Jan; 18(1):130-139. PubMed ID: 31628201
[TBL] [Abstract][Full Text] [Related]
24. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
25. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
26. Effect of Microbiota in the Development of Breast Cancer.
Saud Hussein A; Ibraheem Salih N; Hashim Saadoon I
Arch Razi Inst; 2021 Oct; 76(4):761-768. PubMed ID: 35096312
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Methylobacterium radiotolerance and Sphyngomonas yanoikoaie in Sentinel Lymph Nodes of Breast Cancer Cases.
Yazdi HR; Movafagh A; Fallah F; Alizadeh Shargh S; Mansouri N; Heidary Pour A; Hashemi M
Asian Pac J Cancer Prev; 2016; 17(S3):279-85. PubMed ID: 27165239
[TBL] [Abstract][Full Text] [Related]
28. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
29. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
[TBL] [Abstract][Full Text] [Related]
30. Metaplastic breast cancer: clinicopathological features and its prognosis.
Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
[TBL] [Abstract][Full Text] [Related]
31. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
32. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
33. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
[TBL] [Abstract][Full Text] [Related]
34. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients.
Hogan BV; Peter MB; Shenoy H; Horgan K; Shaaban A
Surg Oncol; 2010 Mar; 19(1):11-6. PubMed ID: 19171479
[TBL] [Abstract][Full Text] [Related]
35. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?
Jones T; Neboori H; Wu H; Yang Q; Haffty BG; Evans S; Higgins S; Moran MS
Ann Surg Oncol; 2013 Sep; 20(9):2866-72. PubMed ID: 23661183
[TBL] [Abstract][Full Text] [Related]
36. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Yoshida T; Ninomiya J; Yoshida M; Hagiwara Y; Kamimura M; Hayashi Y; Inoue K; Tabei T
Breast Cancer; 2007; 14(1):16-24. PubMed ID: 17244989
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
Ma X; Yang X; Yang W; Shui R
Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
[TBL] [Abstract][Full Text] [Related]
38. Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
Kim K; Kim SS; Shin KH; Kim JH; Ahn SD; Choi DH; Park W; Lee SY; Chun M; Kim JH; Kim YB; Cha J; Park HJ; Lee DS; Jung W
Clin Breast Cancer; 2020 Feb; 20(1):51-60. PubMed ID: 31629642
[TBL] [Abstract][Full Text] [Related]
39. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
[TBL] [Abstract][Full Text] [Related]
40. Predictive of 21-gene recurrence score assay in non-estrogen receptor-positive and lymph node-negative breast cancer.
Lu K; Li H; Wu Z; Liu D; Ye H; Xu L; Liu Y
J BUON; 2018; 23(5):1297-1301. PubMed ID: 30570850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]